Dr. Premal Lulla, assistant professor at the Center for Cell and Gene Therapy at Baylor College of Medicine in Houston, details promising results in a clinical trial testing multi-antigen targeted T cell therapy in patients with multiple myeloma. This material relates to a paper that appeared in the Jun. 29, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by P.D. Lulla at Baylor College of Medicine in Houston, TX; and colleagues was titled, "The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.